Search
Now showing items 31-40 of 63
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence
Duy, Cihangir et al. (2021)
Wissenschaftlicher Artikel
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma
Ng, Yuen Lam Dora et al. (2022)
Wissenschaftlicher Artikel
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
Dinardo, Courtney D. et al. (2020)
Wissenschaftlicher Artikel
Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myeloma
Bohl, Stephan R. et al. (2021)
Wissenschaftlicher Artikel
Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial
Ravandi, Farhad et al. (2021)
Wissenschaftlicher Artikel
DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapy
Yosifov, Deyan Yordanov et al. (2020)
Wissenschaftlicher Artikel
Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22; q22.1) acute myeloid leukemia (AML)
Agrawal, Mridul et al. (2020)
Wissenschaftlicher Artikel
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia
Döhner, Konstanze et al. (2020)
Wissenschaftlicher Artikel
Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin
Teich, Katrin et al. (2021)
Wissenschaftlicher Artikel
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia
Condoluci, Adalgisa et al. (2020)
Wissenschaftlicher Artikel